Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corporation    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
11/15/2019 11/18/2019 11/19/2019 11/20/2019 11/21/2019 Date
18 18.18 18.76 18.66 19.34 Last
5459200 2713926 4616446 2497218 9652147 Volume
+1.93% +1.00% +3.19% -0.53% +3.64% Change
Financials (USD)
Sales 2019 290 M
EBIT 2019 -41,6 M
Net income 2019 -6,08 M
Debt 2019 -
Yield 2019 -
Sales 2020 339 M
EBIT 2020 -41,6 M
Net income 2020 -15,5 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -1 309x
P/E ratio 2020 -308x
Capi. / Sales2019 15,9x
Capi. / Sales2020 13,6x
Capitalization 4 609 M
More Financials
Company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and... 
More about the company
Surperformance© ratings of Genscript Biotech Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORPORAT
11/06GENSCRIPT BIOTECH : Voluntary announcement - research and development update
PU
04/17GENSCRIPT BIOTECH : Chinese CDMO, GenScript starts construction of Biotech Comme..
AQ
04/16GENSCRIPT BIOTECH : Chinese CDMO GenScript starts construction of GenScript-Lege..
AQ
03/19Germany's Merck to Work With GenScript to Expand Cell and Gene Therapies in C..
DJ
02/04China Resources, Charoen Pokphand launch $300M life science fund
AQ
2018Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
2018GENSCRIPT BIOTECH : Stock of China's GenScript Plummets on Report Critical of Un..
DJ
2018JOHNSON & JOHNSON : J&J Bets on Chinese Startup That Uses Llama DNA to Fight Can..
DJ
2017GENSCRIPT BIOTECH : Launches Custom Rabbit Monoclonal Antibody Service
PU
2016HONG KONG SMALL-CAPS : ready for China fever?
RE
2016GENSCRIPT BIOTECH : Corporation Finishes Year with Successful Hong Kong IPO
BU
More news
News in other languages on GENSCRIPT BIOTECH CORPORAT

- No features available -

More news
Sector news : Bio Diagnostics & Testing
11/19Akcea, Ionis Close Licensing Agreement with Pfizer on New Drug
DJ
11/19GENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma
DJ
11/18A lot happening on the M&A side
11/18Qiagen shares surge as diagnostics group says open to takeover talks
RE
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
More sector news : Bio Diagnostics & Testing
Chart GENSCRIPT BIOTECH CORPORATION
Duration : Period :
Genscript Biotech Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORPORAT
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 3,52  $
Last Close Price 2,47  $
Spread / Highest target 44,7%
Spread / Average Target 42,1%
Spread / Lowest Target 39,5%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORPORATION84.19%4 608
GUARDANT HEALTH, INC.110.59%7 434
IOVANCE BIOTHERAPEUTICS, INC.148.02%2 899
INVITAE CORPORATION73.42%1 851
MIRACA HOLDINGS INC.12.87%1 446
VERACYTE, INC.104.37%1 282